Mounjaro, manufactured by Eli Lilly and Co., is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar in adults with type 2 diabetes mellitus. Mounjaro received FDA approval in May of 2022. Mounjaro is a glucagon-like peptide-1 (GLP-1) receptor agonist, like Ozempic, which…
Updated: